Company Update (NYSE:UNH): UnitedHealthcare Will Reimburse Kidney Donors’ Travel Expenses, Expanding Life-Saving Access to Kidney Transplants

[Business Wire] – UnitedHealthcare will pay travel expenses for kidney transplant donors, addressing one of the major barriers to living organ donation. Read more on this. UnitedHealth Group Incorporated (UNH) , with a current value of $131.92B, started the session at $139.00. During the trading session, UNH traded between $138.42 to $140.13 with its 52-week range being $95.00 to $140.89. UNH shares are currently priced at 17.67x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 8.92x forward p/e ratio. And for dividend hunters, the company pays shareholders $2.50 per share annually in dividends, yielding 1.80%. In a review of the consensus earnings estimate this quarter, 23 sell-side analysts are looking at $1.89 per share, which would be $0.16 better than the year-ago quarter and a $0.02 sequential decrease. The full-year EPS estimate is $7.88 which would be a $1.43 better than last year’s full-year earnings. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $45.06 Billion. If realized, that would be a 24.27% increase over the year-ago quarter. In terms of ratings, Citigroup Initiated UNH at Buy (Oct 2, 2015). Previously, JP Morgan Initiated UNH at to Overweight. When considering if the stock is under or overvalued, the average price target is $149.90, which is 7.84% above where the stock opened this morning. See more in (NYSE:UNH) Similar Articles: Company Update (NYSE:UNH): UnitedHealthcare Donates $50,000 to Support Health and Wellness Programs in Indiana Company Update (NYSE:UNH): UnitedHealthcare Donates $30,000 to Support Health and Wellness Programs in Missouri Company Update (NYSE:UNH): UnitedHealthcare and Optum Support People Affected by Floods in Illinois